Human phenotypes associated with GATA-1 mutations
- PMID: 18930124
- PMCID: PMC2601579
- DOI: 10.1016/j.gene.2008.09.018
Human phenotypes associated with GATA-1 mutations
Abstract
GATA-1 is one of the six members of the GATA gene family, a group of related transcription factors discovered in the 1980s. In the past few decades, the crucial role of GATA-1 in normal human hematopoiesis has been delineated. As would be expected, mutations in GATA-1 have subsequently been found to have important clinical significance, and are directly linked to deregulated formation of certain blood cell lineages. This paper reviews the functional consequences of GATA-1 mutations by linking specific errors in the gene, or its downstream protein products, to documented human diseases. These five human diseases are: X-linked thrombocytopenia (XLT), X-linked thrombocytopenia with thalassemia (XLTT), congenital erythropoietic porphyria (CEP), transient myeloproliferative disorder (TMD) and acute megarakaryoblastic leukemia (AMKL) associated with Trisomy 21, and, lastly, a particular subtype of anemia associated with the production of GATA-1s, a shortened, mutant isoform of the wild-type GATA-1. The different phenotypic expressions associated with GATA-1 mutations illustrate the integral function of the transcription factor in overall body homeostasis. Furthermore, these direct genotype-phenotype correlations reinforce the importance of unraveling the human genome, as such connections may lead to important therapeutic or preventive therapies.
Similar articles
-
Transcription factor GATA-1 and Down syndrome leukemogenesis.Leuk Lymphoma. 2006 Jun;47(6):986-97. doi: 10.1080/10428190500485810. Leuk Lymphoma. 2006. PMID: 16840187 Review.
-
Frequent mutations in the GATA-1 gene in the transient myeloproliferative disorder of Down syndrome.Blood. 2003 Oct 15;102(8):2960-8. doi: 10.1182/blood-2003-02-0390. Epub 2003 Jun 19. Blood. 2003. PMID: 12816863
-
Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis.Br J Haematol. 2009 Oct;147(1):3-12. doi: 10.1111/j.1365-2141.2009.07789.x. Epub 2009 Jul 6. Br J Haematol. 2009. PMID: 19594743 Review.
-
Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.J Pediatr. 2006 May;148(5):687-9. doi: 10.1016/j.jpeds.2005.12.031. J Pediatr. 2006. PMID: 16737888
-
Are GATA1 mutations occurring at random in Down syndrome transient leukemia?Med Hypotheses. 2014 Aug;83(2):154-9. doi: 10.1016/j.mehy.2014.05.005. Epub 2014 May 20. Med Hypotheses. 2014. PMID: 24880866
Cited by
-
Long-term outcome of hemizygous and heterozygous carriers of a germline GATA1 (G208R) mutation.Ann Hematol. 2011 Mar;90(3):301-6. doi: 10.1007/s00277-010-1088-9. Epub 2010 Oct 5. Ann Hematol. 2011. PMID: 20922527 Free PMC article.
-
GATA1 Activity Governed by Configurations of cis-Acting Elements.Front Oncol. 2017 Jan 9;6:269. doi: 10.3389/fonc.2016.00269. eCollection 2016. Front Oncol. 2017. PMID: 28119852 Free PMC article. Review.
-
A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger.Cells. 2022 Oct 14;11(20):3223. doi: 10.3390/cells11203223. Cells. 2022. PMID: 36291092 Free PMC article.
-
Prevalence of Macrothrombocytopenia in Healthy College Students in Western India.Indian J Hematol Blood Transfus. 2019 Jan;35(1):144-148. doi: 10.1007/s12288-018-0970-9. Epub 2018 Jun 7. Indian J Hematol Blood Transfus. 2019. PMID: 30828162 Free PMC article.
-
Novel insights into the genetic controls of primitive and definitive hematopoiesis from zebrafish models.Adv Hematol. 2012;2012:830703. doi: 10.1155/2012/830703. Epub 2012 Jul 25. Adv Hematol. 2012. PMID: 22888355 Free PMC article.
References
-
- Athale UH, Razzouk BI, Raimondi SC, Tong X, Behm FG, Head DR, Srivastava DK, Rubnitz JE, Bowman L, Pui CH, Raul C, Ribeiro RC. Biology and outcome of childhood acute megakaryoblastic leukemia: a single institution’s experience. Blood. 2001;97:3727–3732. - PubMed
-
- Ahmed M, Sternberg A, Hall G, Thomas A, Smith O, O’Marcaigh A, Wynn R, Stevens R, Addison M, King D, Stewart B, Gibson B, Roberts I, Vyas P. Natural history of GATA1 mutations in Down syndrome. Blood. 2004;103:2480–2489. - PubMed
-
- Balduini CL, Pecci A, Loffredo G, Izzo P, Noris P, Grosso M, Bergamaschi G, Rosti V, Magrini U, Ceresa IF, Conti V, Poggi V, Savoia A. Effects of the R216Q mutation of GATA-1 on eryrthopoiesis and megakaryocytopoiesis. Thrombosis and Haemostasis. 2004;91:129–140. - PubMed
-
- Cantor AB. GATA Transcription Factors in Hematologic Disease. Int J Hematol. 2005;81:378–384. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous